Cellectar Biosciences, Inc. (CLRB) vs Dare Bioscience, Inc. (DARE)
A side-by-side comparison of Cellectar Biosciences, Inc. and Dare Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.57HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
Total return — CLRB vs DARE
growth of $100 · dividends reinvested · last 10yCLRB -100.0% (-55.5%/yr)DARE -99.3% (-39.1%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
CLRB DARE
CLRB vs DARE: by the numbers
- •CLRB is the larger company ($13M vs $13M market cap).
- •Both run net losses; CLRB's is the smaller (0.00% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | CLRB | DARE |
|---|---|---|
| P/S ratio | N/A | 9.16 |
| P/B ratio | 0.42 | N/A |
Profitability
| Metric | CLRB | DARE |
|---|---|---|
| Gross margin | 0.00% | -137.55% |
| Operating margin | 0.00% | -1315.51% |
| Net margin | 0.00% | -804.37% |
| ROE | -74.73% | N/A |
| ROIC | -74.94% | -203.50% |
Growth (annualized)
| Metric | CLRB | DARE |
|---|---|---|
| Total return CAGR (5Y) | -60.51% | -46.35% |
Frequently asked
- How have CLRB and DARE total returns compared?
- Over the past 10 years, CLRB delivered -55.35% and DARE delivered -39.10% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.